MITOINDEX
DEAD

Serial Number

79301197

Owner

Minovia Therapeutics Ltd.

Attorney

Kevin D. McCarthy

Filing Date

Oct 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MITOINDEX Trademark

Serial Number: 79301197

MITOINDEX is a trademark filed by Minovia Therapeutics Ltd. on October 18, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Minovia Therapeutics Ltd. (3 trademarks)

3 Ha'sadna st.

Entity Type: 99

Trademark Details

Filing Date

October 18, 2020

Registration Date

Not Registered

Goods & Services

Medical diagnostic testing, monitoring and reporting services; medical diagnostic services, namely, assessing the level of healthy mitochondria or mutated mitochondria, mitochondrial activity; medical diagnostic testing and reporting services in the fields of DNA sequencing, DNA and RNA analysis, and genetic analysis; medical diagnostic testing and reporting services, namely, protein sequencing services and protein analysis; medical consultancy services in relation to diagnostic and assay products; consulting services in the field of diagnostic medical testing

Scientific research in the field of assessing the level of healthy mitochondria and mutated mitochondria, mitochondrial activity; medical research relating to assessing the level of healthy mitochondria and mutated mitochondria, mitochondrial activity; scientific advisory services in the fields of technical diagnostic products, chemistry, biotechnology and biochemistry for assessing the level of healthy mitochondria and mutated mitochondria, and mitochondrial related activity; biotechnology and biological research and testing of the level of healthy mitochondria and or mutated mitochondria, mitochondrial activity; scientific research services, namely, gene analysis and sequencing, DNA analysis and sequencing, and nucleic acid analysis; scientific research services, namely, protein analysis and protein sequencing services; software as a service (saas) in relation to diagnostic and assay products; software as a service (saas) featuring software for assessing the level of healthy mitochondria and mutated mitochondria, mitochondrial activity; consulting services in the fields of laboratory testing and diagnostics

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 3, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 11, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 22, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 22, 2023 FICR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 22, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 22, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 22, 2022 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 21, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 1, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 1, 2022 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 3, 2022 GNFN
FINAL REFUSAL E-MAILED
May 3, 2022 GNFR
FINAL REFUSAL WRITTEN
May 3, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2021 GNRT
NON-FINAL ACTION WRITTEN
Oct 13, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2021 TROA
REFUSAL PROCESSED BY IB
Apr 19, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 26, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 25, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 22, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 8, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 31, 2020 REPR